Attached files
| file | filename |
|---|---|
| EX-4.1 - EXHIBIT 4.1 DESCRIPTION OF CAPITAL STOCK - VOLITIONRX LTD | f10k123119_ex4z1.htm |
| 10-K - FORM 10-K ANNUAL REPORT - VOLITIONRX LTD | f10k123119_10k.htm |
| EX-32.1 - EXHIBIT 32.1 SECTION 906 CERTIFICATION - VOLITIONRX LTD | f10k123119_ex32z1.htm |
| EX-31.2 - EXHIBIT 31.2 SECTION 302 CERTIFICATION - VOLITIONRX LTD | f10k123119_ex31z2.htm |
| EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATION - VOLITIONRX LTD | f10k123119_ex31z1.htm |
| EX-23.1 - EXHIBIT 23.1 AUDITOR'S CONSENT - VOLITIONRX LTD | f10k123119_ex23z1.htm |
| EX-10.22 - EXHIBIT 10.22 AMENDMENT NO. 1 TO CLINICAL STUDY AGREEMENT - VOLITIONRX LTD | f10k123119_ex10z22.htm |
Exhibit 21.1
SUBSIDIARIES OF VOLITIONRX LIMITED
Name of Subsidiary | State or other Jurisdiction of |
|
|
Singapore Volition Pte. Limited (100% subsidiary of VolitionRx Limited)
| Singapore |
Belgian Volition SPRL (99.9% subsidiary of Singapore Volition Pte. Limited)
| Belgium |
Volition Diagnostics UK Limited (100% subsidiary of Belgian Volition SPRL)
| United Kingdom |
Volition America, Inc. (100% subsidiary of Belgian Volition SPRL)
| Delaware |
Volition Veterinary Diagnostics Development LLC. (87.5% subsidiary of Belgian Volition SPRL) | Texas |